Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FJG37
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,343
Award facts
- Contract value 100% obligated
- $35,342.61 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $35,342.61 to AmerisourceBergen Drug Corp for the supply of Biktarvy (50-200-25 mg tablets) in quantities of 30 units. This contract, issued on August 6, 2025, with an ultimate completion date of August 7, 2025, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The pharmaceutical product will be delivered to the contractor's headquarters location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, fulfills a critical role in the federal medical supply chain, particularly supporting Defense Health Agency and military healthcare systems. The company's comprehensive IDC vehicle enables the supply of pharmaceutical products, medical devices, vaccines, and specialized healthcare commodities across multiple therapeutic domains to support military and veteran healthcare programs globally. This specific delivery order for Biktarvy, an antiretroviral medication, reflects the company's ongoing role in providing essential pharmaceuticals through the DLA's competitive procurement processes for federal healthcare needs.
Quick answers
Who was awarded contract SPE2DB25FJG37?
SPE2DB25FJG37 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 6, 2025.
How much is contract SPE2DB25FJG37 worth?
The government has obligated $35,343 on SPE2DB25FJG37.
Is contract SPE2DB25FJG37 an order under another contract?
Yes. SPE2DB25FJG37 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJG37 competed?
The extent of competition for SPE2DB25FJG37 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award